Ecarin Clotting Time Measurement

Known as: ECT, Ecarin Clotting Time 
The determination of the activity of thrombin inhibitors in a biological specimen based on the generation of meizothrombin.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2015
Highly Cited
2015
BACKGROUND Specific reversal agents for non-vitamin K antagonist oral anticoagulants are lacking. Idarucizumab, an antibody… (More)
  • table 1
  • table 2
Is this relevant?
2013
2013
BACKGROUND Clinicians managing patients receiving the direct thrombin inhibitor dabigatran may benefit in being able to determine… (More)
Is this relevant?
Review
2010
Review
2010
Dabigatran etexilate is an oral, reversible direct thrombin inhibitor that is approved in the EU and several other countries for… (More)
Is this relevant?
Highly Cited
2010
Highly Cited
2010
Dabigatran etexilate is an oral direct thrombin inhibitor in clinical development for the prevention and treatment of… (More)
Is this relevant?
Review
2008
Review
2008
As the only oral anticoagulation option available in the United States, warfarin use remains widespread. However, concerns of… (More)
Is this relevant?
Highly Cited
2007
Highly Cited
2007
AIMS The novel direct thrombin inhibitor (DTI), dabigatran etexilate (Boehringer Ingelheim Pharma GmbH & Co. KG), shows potential… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
2006
2006
Standard activated clotting time (ACT) tests have a poor correlation to bivalirudin levels, leading to uncertainty regarding… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2005
2005
Background: Ecarin Clotting Time (ECT) assay specifically determines the inhibition of meizothrombin by direct thrombin… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 4
Is this relevant?
2003
2003
T he problem of heparin-induced thrombocytopenia (HIT) among patients undergoing cardiac surgery is increasingly being… (More)
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
1997
1997
The use of recombinant (r) hirudin as an anticoagulant in performing extracorporeal circulation systems including cardiopulmonary… (More)
Is this relevant?